Silicon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Silicon Therapeutics's estimated annual revenue is currently $54.5M per year.
- Silicon Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Silicon Therapeutics has 271 Employees.
Silicon Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO | Reveal Email/Phone |
Silicon Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Silicon Therapeutics?
Silicon Therapeutic’s (STX) mission is to design novel therapeutics for the advancement of human health by building the most accurate in silico models of highly implicated human drug targets. STX has developed its own proprietary In Silico Target Engineering (INSITE) platform around this goal. Currently, we are applying the INSITE platform against target proteins that experience significant conformational change, which often renders them inaccessible to traditional drug discovery methods. STX plans to maintain scientific leadership in the field by first continuing to improve the science behind the INSITE platform, in addition to applying the INSITE platform to drive STX’s pipeline toward the clinic.
keywords:N/AN/A
Total Funding
271
Number of Employees
$54.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Silicon Therapeutics News
Harbour Biomed Therapeutics Ltd., of Suzhou, China, ... he served as chief medical officer at Silicon Therapeutics LLC and chief of medical...
... Therapeutics as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank.
Before joining the Company, he served as the chief medical officer at Silicon Therapeutics and the chief of medical oncology at Evelo...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $96.3M | 271 | -4% | N/A |
#2 | $96.3M | 271 | -14% | N/A |
#3 | $42.2M | 271 | -5% | $39.1M |
#4 | $15M | 272 | 6% | N/A |
#5 | $42.4M | 272 | -8% | $87.5M |